Preferences for Oral Anticoagulants in Atrial Fibrillation: a Best–Best Discrete Choice Experiment

被引：0
|
作者：
Peter Ghijben
Emily Lancsar
Silva Zavarsek
机构：
[1] Monash University,Centre for Health Economics
来源：
PharmacoEconomics | 2014年 / 32卷
关键词：
Warfarin; Dabigatran; Rivaroxaban; Oral Anticoagulant; Stroke Risk;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1115 / 1127
页数：12
相关论文
共 50 条
  • [21] New oral anticoagulants in atrial fibrillation
    Turpie, Alexander G. G.
    EUROPEAN HEART JOURNAL, 2008, 29 (02) : 155 - 165
  • [22] Prostate cancer survivors’ preferences on the delivery of diet and lifestyle advice: a pilot best-worst discrete choice experiment
    Luke A. Robles
    Stuart J. Wright
    Lucy Hackshaw-McGeagh
    Ellie Shingler
    Constance Shiridzinomwa
    J. Athene Lane
    Richard M. Martin
    Sorrel Burden
    Pilot and Feasibility Studies, 6
  • [23] Prostate cancer survivors' preferences on the delivery of diet and lifestyle advice: a pilot best-worst discrete choice experiment
    Robles, Luke A.
    Wright, Stuart J.
    Hackshaw-McGeagh, Lucy
    Shingler, Ellie
    Shiridzinomwa, Constance
    Lane, J. Athene
    Martin, Richard M.
    Burden, Sorrel
    PILOT AND FEASIBILITY STUDIES, 2020, 6 (01)
  • [24] Estimating decision rule differences between 'best' and 'worst' choices in a sequential best worst discrete choice experiment
    Gerzinic, Nejc
    van Cranenburgh, Sander
    Cats, Oded
    Lancsar, Emily
    Chorus, Caspar
    JOURNAL OF CHOICE MODELLING, 2021, 41
  • [25] Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation
    Weitz, Jeffrey I.
    Eikelboom, John
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (02) : 257 - 270
  • [26] EFFICACY AND SAFETY OF NON-VITAMIN K ORAL ANTICOAGULANTS (NOAC) COMPARED WITH WARFARIN AT ITS BEST IN PATIENTS WITH ATRIAL FIBRILLATION
    Oldgren, J.
    Friberg, L.
    INTERNATIONAL JOURNAL OF STROKE, 2016, 11 (SUPP 3) : 46 - 46
  • [27] FOCUS GROUPS EXPLORING EXPERIENCES WITH AND PREFERENCES FOR ORAL ANTICOAGULANTS IN PEOPLE WITH NONVALVULAR ATRIAL FIBRILLATION
    Barrett, A.
    DiBenedetti, D.
    Phatak, H.
    Masseria, C.
    Kamble, S.
    VALUE IN HEALTH, 2016, 19 (03) : A51 - A51
  • [28] Importance of attributes and willingness to pay for oral anticoagulant therapy in patients with atrial fibrillation in China: A discrete choice experiment
    Zhao, Jiaxi
    Wang, Hao
    Li, Xue
    Hu, Yang
    Yan, Vincent K. C.
    Wong, Carlos K. H.
    Guo, Yutao
    Cheung, Marco K. H.
    Lip, Gregory Y. H.
    Siu, Chung-Wah
    Tse, Hung-Fat
    Chan, Esther W.
    PLOS MEDICINE, 2021, 18 (08)
  • [29] Trends of use and factors that determine the choice of oral anticoagulants in women and men with atrial fibrillation
    Lenglet, Aurelie
    Qazi, Jakub Z. Z.
    Boivin Proulx, Laurie-Anne
    Legault, Catherine
    Dorais, Marc
    Perreault, Sylvie
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022, 10 (06):
  • [30] Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: Practical Considerations on the Choice of Agent and Dosing
    Farmakis, Dimitrios
    Davlouros, Periklis
    Giamouzis, Gregory
    Giannakoulas, George
    Pipilis, Athanasios
    Tsivgoulis, Georgios
    Parissis, John
    CARDIOLOGY, 2018, 140 (02) : 126 - 132
12345